Healthcare AI startup Promedius (CEO Hyunjin Bae) introduced its AI solutions for the early detection and management of musculoskeletal and metabolic diseases, including osteoporosis, at the Korean Academy of Family Medicine’s 1st International Congress on Primary Care 2024, held April 19-21 at The K Hotel Seoul Convention Center. The congress was the first international congress in Korea organized by the Korean Academy of Family Medicine in conjunction with the Annual Conference of Family Doctors 2024, featuring a variety of symposia, training courses, and workshops.

Dr. Miso Jang, MD, PhD, Medical Director of Promedius, presented "Introduction to Medical Image-based AI Research and Interpretation of Results when Using Medical AI Devices" and "Multi-center Validation and Evaluation of Osteoporosis Screening Deep Learning Models using Chest Radiographs". These sessions received great attention from audience as they introduced the robust performance of the osteoporosis screening model using chest X-ray and the application of AI models in the medical field.

Promedius is expected to participate as a Platinum Sponsor at the Asia Pacific Singapore Osteoporosis and Other Metabolic Bone Disorders Summit in Singapore from May 17-19, where it will also host a luncheon symposium on Opportunity Screening for Osteoporosis with AI Solutions.